Effect of Flaxseed oil in hand dermatitis

Comparison between Flaxseed oil and Eucerin in improving the symptoms of Hand contact dermatitis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200229046641N1

Enrollment

Registered

2022-06-01

Start date

2022-05-26

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand contact dermatitis. hand contact dermatitis

Interventions

Intervention 1: Intervention group: The dose of the drug for each hand is 1 gram, which is explained to the patient in the form of a fingertip unit (from the skin folds of the adult finger to the tip

Eligibility

Sex/Gender

All

Age

5 Years to 70 Years

Inclusion criteria

Inclusion criteria: The patient's cooperation to eliminate or reduce environmental irritants and is bound to cooperate for regular use of the drug under study and referral at the appointed time after signing the informed consent form Having symptoms of moderate contact dermatitis Age over 5 years up to 70 years Do not take anti-allergy and anti-itch drugs

Exclusion criteria

Exclusion criteria: History of neurological and mental illness Specific skin allergies Taking systemic anti-allergy, anti-pruritic and immunosuppressive drugs Use of topical medications during the 2 weeks before the start of the research project, Having obsessive-compulsive disorder for frequent hand washing, Use of systemic immunosuppressive drugs one month before the start of the study,

Design outcomes

Primary

Measure	Time frame
Erythem. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Papule. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Vesicle. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Fissure. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Scaling. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Edema. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.	—

Measure

Time frame

Erythem. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Papule. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Vesicle. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Fissure. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Scaling. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.;Edema. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on HECSI questionnaires.

—

Secondary

Measure	Time frame
Patients' quality of life index. Timepoint: Patients are examined at the beginning of the study and at the end of the first week and then at the end of the second and fourth weeks. Method of measurement: Will be examined based on DLQI questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Dadashi

Ghoum University of Medical Sciences

admin@irct.ir+98 25 3776 4074

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026